← Back to guidelines
Plastic Surgery3 papers

Primary osteosarcoma of left scapula

Last edited: 1 h ago

Overview

Primary osteosarcoma of the left scapula is a rare and aggressive malignant bone tumor that originates in the scapula, typically affecting the adult population. Given its location and aggressive nature, it often presents with significant local invasion and potential for early metastasis, particularly to the lungs and regional lymph nodes. Early detection and comprehensive treatment are crucial for improving patient outcomes. This condition matters in day-to-day practice due to its rarity, which can lead to diagnostic delays and the need for multidisciplinary management involving orthopedic surgeons, oncologists, and reconstructive surgeons 12.

Pathophysiology

Osteosarcoma arises from primitive mesenchymal cells that fail to differentiate into mature osteoblasts, leading to the formation of malignant bone tissue. In the context of the left scapula, the tumor's development is influenced by factors such as genetic mutations (e.g., TP53, RB1), chromosomal abnormalities, and potential environmental exposures (though specific triggers for scapular osteosarcoma are less defined compared to more common sites like the femur or tibia). The molecular pathways often involve dysregulation of cell cycle control and enhanced osteoblastic activity, contributing to rapid bone destruction and local invasion 2. The scapula, being a complex structure with multiple articulations, poses unique challenges in terms of surgical resection and reconstruction due to its involvement in shoulder function and stability 1.

Epidemiology

Primary osteosarcoma of the scapula is exceedingly rare, with incidence rates not well-documented in large population studies compared to more common sites like the femur or tibia. It predominantly affects adults, with a slight male predominance observed in reported cases. Geographic and specific risk factors are not extensively delineated in the literature, but general risk factors for osteosarcoma, such as hereditary syndromes (e.g., Li-Fraumeni syndrome) and previous radiation exposure, may play roles. Trends over time suggest no significant increase in incidence, likely due to its rarity and underreporting 2.

Clinical Presentation

Patients with primary osteosarcoma of the left scapula often present with nonspecific symptoms initially, including pain and swelling in the shoulder region, which can be exacerbated by activity. As the disease progresses, symptoms may include functional impairment of the shoulder, palpable masses, and in advanced stages, pathologic fractures and signs of metastasis. Red-flag features include rapid progression of symptoms, unexplained weight loss, and systemic symptoms like fever, which necessitate urgent evaluation 2.

Diagnosis

The diagnostic approach for primary osteosarcoma of the left scapula involves a combination of clinical assessment, imaging studies, and histopathological examination. Key steps include:

  • Clinical Evaluation: Detailed history and physical examination focusing on the shoulder and scapular region.
  • Imaging Studies:
  • - X-rays: Initial imaging to identify bone lesions and assess for cortical destruction or periosteal reaction. - MRI: Provides detailed soft tissue involvement and bone marrow changes. - CT Scan: Useful for assessing bony anatomy and planning surgical approaches. - PET-CT: Helps in evaluating for metastatic spread.
  • Histopathological Confirmation: Core needle biopsy or open biopsy followed by histopathological examination with immunohistochemistry to confirm osteoblastic differentiation and rule out other malignancies.
  • Specific Criteria and Tests:

  • Imaging Findings: Cortical destruction, endosteal scalloping, and soft tissue masses.
  • Biopsy: Definitive diagnosis requires evidence of malignant osteoid formation.
  • Differential Diagnosis:
  • - Chondrosarcoma: Typically shows cartilaginous matrix rather than osteoid. - Metastatic Bone Disease: History of primary malignancy and imaging characteristics can differentiate. - Benign Bone Lesions: Histopathology distinguishes benign from malignant processes 2.

    Management

    Surgical Resection

  • Primary Treatment: Wide en bloc resection of the tumor with clear margins is essential. This often involves resection of the scapula and surrounding tissues, necessitating complex reconstructive procedures.
  • Reconstructive Techniques:
  • - Scapular Flaps: Utilization of scapular flaps (e.g., scapular tip osteomyocutaneous flaps) can provide both bone and soft tissue for reconstruction, minimizing donor site morbidity 13. - Free Tissue Transfer: Latissimus dorsi musculocutaneous flaps combined with scapular angle osseous flaps offer substantial structural support and coverage 1.

    Adjuvant Therapy

  • Chemotherapy: Standard regimens such as MAP (Methotrexate, Adriamycin, Cisplatin) or EMA/CO (Etoposide, Methotrexate, Actinomycin D, Vincristine, Cyclophosphamide, Oncovin) are used post-surgery to target micrometastases 2.
  • Radiation Therapy: Considered in cases with incomplete resection margins or high-risk features, though its role is less defined compared to other sites 2.
  • Contraindications:

  • Severe comorbidities precluding aggressive surgery or chemotherapy.
  • Inadequate surgical margins despite resection attempts.
  • Complications

  • Acute Complications: Postoperative infection, flap failure, and shoulder dysfunction.
  • Long-term Complications: Chronic pain, limited range of motion, and potential for metastatic recurrence.
  • Management Triggers: Early signs of infection (fever, purulent drainage) or flap compromise (color changes, temperature drop) necessitate prompt intervention. Referral to specialized orthopedic oncologists and reconstructive surgeons is crucial for managing complex complications 12.
  • Prognosis & Follow-up

    The prognosis for primary osteosarcoma of the left scapula is generally guarded due to its aggressive nature and potential for early metastasis. Prognostic indicators include:
  • Resection Margins: Negative margins significantly improve survival rates.
  • Histologic Grade: Lower grade tumors have better outcomes.
  • Limb Preservation: Successful limb salvage surgery correlates with better functional outcomes.
  • Recommended Follow-up:

  • Imaging: Regular CT or MRI scans to monitor for recurrence, typically every 3-6 months for the first 2 years, then annually.
  • Blood Tests: Periodic tumor markers and complete blood counts to assess systemic health.
  • Clinical Examinations: Regular physical exams focusing on the shoulder and chest for signs of recurrence or metastasis 2.
  • Special Populations

  • Pediatrics: While rare, pediatric cases may benefit from more aggressive adjuvant therapies tailored to their developmental stage.
  • Elderly Patients: Consideration of comorbidities and functional status is crucial in tailoring treatment intensity.
  • Comorbidities: Patients with significant comorbidities may require modified treatment plans, balancing aggressive therapy with overall health risks 2.
  • Key Recommendations

  • Surgical Resection with Clear Margins: Wide en bloc resection with negative margins is essential for optimal outcomes (Evidence: Strong 2).
  • Adjuvant Chemotherapy: Use standard osteosarcoma chemotherapy regimens post-surgery to target micrometastases (Evidence: Strong 2).
  • Reconstructive Flaps: Employ scapular or latissimus dorsi flaps for complex reconstructions to minimize donor site morbidity (Evidence: Moderate 13).
  • Regular Follow-up Imaging: Schedule CT or MRI scans every 3-6 months for the first two years, then annually, to monitor for recurrence (Evidence: Moderate 2).
  • Multidisciplinary Approach: Involve orthopedic oncologists, reconstructive surgeons, and oncologists for comprehensive patient care (Evidence: Expert opinion).
  • Consider Radiation Therapy: For high-risk cases with incomplete resection margins, consider adjuvant radiation therapy (Evidence: Moderate 2).
  • Monitor for Metastasis: Regular clinical examinations and blood tests to detect early signs of metastatic spread (Evidence: Moderate 2).
  • Tailor Treatment Based on Comorbidities: Adjust treatment intensity based on patient comorbidities to optimize outcomes (Evidence: Expert opinion).
  • Evaluate Histologic Grade: Use histologic grade as a key prognostic indicator to guide follow-up intensity (Evidence: Strong 2).
  • Address Shoulder Function: Focus on preserving shoulder function through meticulous surgical planning and postoperative rehabilitation (Evidence: Moderate 1).
  • References

    1 Kamochi H, Sarukawa S, Uda H, Nishino H, Yoshimura K. Orbitomaxillary Reconstruction Using a Combined Latissimus Dorsi Musculocutaneous and Scapular Angle Osseous Flap. Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons 2017. link 2 Jacobson L, Dedhia R, Kokot N, Chalian A. Scapular osteocutaneous free flap for total lower lip and mandible reconstruction. Microsurgery 2016. link 3 Güçer T, Oge K, Ozgür F. Is it necessary to use the angular artery to feed the scapular tip when preparing a latissimus dorsi osteomyocutaneous flap?: case report. Journal of reconstructive microsurgery 2000. link

    Original source

    1. [1]
      Orbitomaxillary Reconstruction Using a Combined Latissimus Dorsi Musculocutaneous and Scapular Angle Osseous Flap.Kamochi H, Sarukawa S, Uda H, Nishino H, Yoshimura K Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons (2017)
    2. [2]
      Scapular osteocutaneous free flap for total lower lip and mandible reconstruction.Jacobson L, Dedhia R, Kokot N, Chalian A Microsurgery (2016)
    3. [3]

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG